Vascularized Jejunal Tube

Author(s):  
David C. Van Der Zee ◽  
Stefaan S. H. Tytgat ◽  
Maud Y. A. Lindeboom
Keyword(s):  
Critical Care ◽  
2021 ◽  
Vol 25 (1) ◽  
Author(s):  
Patrick M. Honore ◽  
Sebastien Redant ◽  
Thierry Preseau ◽  
Sofie Moorthamers ◽  
Keitiane Kaefer ◽  
...  

Author(s):  
Shannon M. Malloy ◽  
Laura C. Nuzzi ◽  
Benjamin Zendejas ◽  
Amir H. Taghinia ◽  
Brian I. Labow

2010 ◽  
Vol 21 (2) ◽  
pp. S91
Author(s):  
M. Watanabe ◽  
A.I. Alomari ◽  
H.M. Padua ◽  
G. Chaudry
Keyword(s):  

Author(s):  
P Podgorny ◽  
P McCann ◽  
K Toore ◽  
G Tremain ◽  
A Lazarescu ◽  
...  

Background: ILI has been in use in Canada since 2011 to treat advanced PD. We review the benefits and complications of ILI for PD in a tertiary movement disorders center in Canada. Methods: Detailed chart review of patients treated with ILI at including motor UPDRS scores, ILI pump and PEG-J tube complications. Patients and caregivers were interviewed at regular clinic follow up about their experience with ILI. Results: 13 patients received ILI [10M, 3F; mean age 65.6 yrs, range (51.8-79.5); PD duration 14.2 yrs, range (9.1-22.0); mean follow-up 1.8 yrs, range (0.2-4.8)]. Patients reported improvement in motor function, decreased dyskinesias and ‘OFF times’ [mean motor UPDRS: pre-ILI 37.1, 1-6months post-ILI 27.5]. Common complications included dislodgement, knotting or blockage of the jejunal tube extension requiring endoscopic re- insertion (29 incidents in 6 patients over 5 yrs). Four patients discontinued Duodopa treatment, for reasons of declining cognition, inability to care for the pump, and/or minimal benefit. Conclusions: ILI is useful for the treatment of advanced PD, in patients that can care for the pump apparatus.


2020 ◽  
Vol 48 (8) ◽  
pp. 030006052092912
Author(s):  
Hendrik Christian Albrecht ◽  
Mateusz Trawa ◽  
Stephan Gretschel

Postoperative nutrition via a jejunal tube after major abdominal surgery is usually well tolerated. However, some patients develop nonocclusive mesenteric ischemia (NOMI). This morbid complication has a grave prognosis with a mortality rate of 41% to 100%. Early symptoms are nonspecific, and no treatment guideline is available. We reviewed cases of NOMI at our institution and cases described in the literature to identify factors that impact the clinical course. Among five patients, three had no necrosis and one had segmental necrosis and perforation. These patients recovered with limited resection and decompression of the bowel and abdominal compartment. In one patient with extended bowel necrosis at the time of re-laparotomy, NOMI progressed and the patient died of multiple organ failure. The extent of small bowel necrosis at the time of re-laparotomy is a relevant prognostic factor. Therefore, early diagnosis and treatment of NOMI can improve the prognosis. Clinical symptoms of abdominal distension, cramps and high reflux plus paraclinical signs of leukocytosis, hypotension and computed tomography findings of a distended small bowel with pneumatosis intestinalis and portal venous gas can help to establish the diagnosis. We herein introduce an algorithm for the diagnosis and management of NOMI associated with jejunal tube feeding.


2000 ◽  
Vol 118 (4) ◽  
pp. A161
Author(s):  
David Karsenti ◽  
Jean-Pierre Barbieux ◽  
Pascal Bourlier ◽  
Beatrice Scotto ◽  
Etienne Dorval ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document